NewsRx

Search our medical news database

Cancer Weekly

Susan Hasty, Publisher

Table of Contents . . . March 27th, 1995

Non-Subscriber - Summaries Only

Related Areas: Other Issues in Cancer Weekly | Other Publications

Viral Vectors - Results Encouraging in Brain Cancer Gene Therapy Trials

Anitisense Therapy - "Regulation of Malignant B-1 Cells by IL-10 Antisense Oligonucleotides."

Cancer Vaccines - "Enhancement of Cell-Mediated Immunity in Melanoma Patients Immunized with Murine Anit-Idiotypic Mabs (MELIMMUNE)."

Immunology - Gene Therapy - "Gene Therapy of Human Melanoma by Particle Bombardment."

Intravenous Devices - "Experience with the PAS-Port Venous Access Device in Patients with Gynecologic Malignancies."

Transfusion Medicine - "Conservative Management of Chemotherapeutic-Induced Thrombocytopenia in Women with Gynecologic Cancers."

Astrocytomas - Genetic Lesions of the p53 Gene - "Single Cell Monitoring of Growth Arrest and Morphological Changes Induced by Transfer of Wild-Type p53 Alleles to Glioblastoma Cells."

Diagnostics - Expression of the CD30 Molecule - "CD30 Antigen in Embryonal Carcinoma and Embryogenesis and Release of the Soluble Molecule."

Human Papillomavirus - Design of Subunit Vaccines - "Peptide Engineering Allows Cytotoxic T-Cell Vaccination Against Human Papillomavirus Tumour Antigen, E6."

Melanoma - Interferon Responsiveness - "Resistance of Melanoma Cell Lines to Interferons Correlates with Reduction of IFN-Induced Tyrosine Phosphorylation - Induction of the Anti-Viral State by IFN is Prevented by Tyrosine Kinase Inhibitors."

Ovarian Cancer - Activation of c-K-ras Oncogene - "Detection of c-K-ras Point Mutation in Ovarian Cancer."

Ovarian Cancer - Therapy - "Platinum Plus Cyclophosphamide Plus Radiotherapy is Superior to Platinum Alone in 'High-Risk' Epithelial Ovarian Cancer (Residual Negative and Either Stage I or II, Grade 3, or S

Therapy - Combined Hyperthermia and Chemotherapy - "A New Approach using Local Combined Microwave Hyperthermia and Chemotherapy in Superficial Transitional Bladder Carcinoma Treatment."

Return to Top of Page

NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook